Cefoxitin in treatment of obstetric and gynecologic infections.

Richard L Sweet, M. Robbie, K. Hadley

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Cefoxitin was found to be an effective and safe agent for the treatment of infections of the female genital tract that were associated with a variety of aerobic and anaerobic bacteria, including Streptococcus, Escherichia coli, and Bacteroides species. The overall clinical response was 91%. The major cause of failure was the presence of an abscess requiring surgical drainage. Both the intravenous and the intramuscular routes of administration for cefoxitin were tolerated well or moderately well by most patients.

Original languageEnglish (US)
Pages (from-to)202-205
Number of pages4
JournalReviews of Infectious Diseases
Volume1
Issue number1
StatePublished - Jan 1979

Fingerprint

Cefoxitin
Obstetrics
Reproductive Tract Infections
Aerobic Bacteria
Bacteroides
Anaerobic Bacteria
Infection
Streptococcus
Abscess
Drainage
Escherichia coli
Therapeutics

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Cefoxitin in treatment of obstetric and gynecologic infections. / Sweet, Richard L; Robbie, M.; Hadley, K.

In: Reviews of Infectious Diseases, Vol. 1, No. 1, 01.1979, p. 202-205.

Research output: Contribution to journalArticle

@article{8959f472f9474365b14a328cb033be92,
title = "Cefoxitin in treatment of obstetric and gynecologic infections.",
abstract = "Cefoxitin was found to be an effective and safe agent for the treatment of infections of the female genital tract that were associated with a variety of aerobic and anaerobic bacteria, including Streptococcus, Escherichia coli, and Bacteroides species. The overall clinical response was 91{\%}. The major cause of failure was the presence of an abscess requiring surgical drainage. Both the intravenous and the intramuscular routes of administration for cefoxitin were tolerated well or moderately well by most patients.",
author = "Sweet, {Richard L} and M. Robbie and K. Hadley",
year = "1979",
month = "1",
language = "English (US)",
volume = "1",
pages = "202--205",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Cefoxitin in treatment of obstetric and gynecologic infections.

AU - Sweet, Richard L

AU - Robbie, M.

AU - Hadley, K.

PY - 1979/1

Y1 - 1979/1

N2 - Cefoxitin was found to be an effective and safe agent for the treatment of infections of the female genital tract that were associated with a variety of aerobic and anaerobic bacteria, including Streptococcus, Escherichia coli, and Bacteroides species. The overall clinical response was 91%. The major cause of failure was the presence of an abscess requiring surgical drainage. Both the intravenous and the intramuscular routes of administration for cefoxitin were tolerated well or moderately well by most patients.

AB - Cefoxitin was found to be an effective and safe agent for the treatment of infections of the female genital tract that were associated with a variety of aerobic and anaerobic bacteria, including Streptococcus, Escherichia coli, and Bacteroides species. The overall clinical response was 91%. The major cause of failure was the presence of an abscess requiring surgical drainage. Both the intravenous and the intramuscular routes of administration for cefoxitin were tolerated well or moderately well by most patients.

UR - http://www.scopus.com/inward/record.url?scp=0018334046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018334046&partnerID=8YFLogxK

M3 - Article

C2 - 318223

AN - SCOPUS:0018334046

VL - 1

SP - 202

EP - 205

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 1

ER -